Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
21.69
+1.42 (7.01%)
At close: Dec 5, 2025, 4:00 PM EST
21.90
+0.21 (0.97%)
After-hours: Dec 5, 2025, 7:59 PM EST
Keros Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 64.45 | -187.35 | -152.99 | -104.68 | -58.74 | -45.36 | |
| Depreciation & Amortization | 1.44 | 1.23 | 0.82 | 0.67 | 0.38 | 0.28 | |
| Loss (Gain) From Sale of Assets | -0.01 | - | 0 | 0.01 | 0.05 | - | |
| Stock-Based Compensation | 30.59 | 34.87 | 28.76 | 18.68 | 11.72 | 4.1 | |
| Other Operating Activities | 2.36 | 1.82 | 1.55 | 0.94 | 0.52 | 1.82 | |
| Change in Accounts Receivable | -3.1 | -2.6 | -0.14 | 18 | -18 | - | |
| Change in Accounts Payable | -2.6 | -0.25 | 1.61 | -0.41 | 1.49 | 0.06 | |
| Change in Unearned Revenue | 0.16 | - | - | - | - | - | |
| Change in Other Net Operating Assets | -8.64 | -8.59 | -4.12 | -3.28 | 0.45 | 2.21 | |
| Operating Cash Flow | 88.79 | -160.87 | -124.51 | -70.06 | -62.15 | -36.89 | |
| Capital Expenditures | -1.71 | -1.93 | -2.46 | -1.24 | -1.02 | -0.29 | |
| Investing Cash Flow | -1.71 | -1.93 | -2.46 | -1.24 | -1.02 | -0.29 | |
| Issuance of Common Stock | 75.71 | 392.28 | 179.05 | 120.4 | 28.55 | 259.94 | |
| Other Financing Activities | - | -0.45 | -0.09 | -0.09 | - | -19.89 | |
| Financing Cash Flow | 75.71 | 391.82 | 178.96 | 120.31 | 28.55 | 296.04 | |
| Net Cash Flow | 162.79 | 229.02 | 51.98 | 49.01 | -34.62 | 258.86 | |
| Free Cash Flow | 87.08 | -162.8 | -126.97 | -71.3 | -63.17 | -37.19 | |
| Free Cash Flow Margin | 35.30% | -4585.91% | -84087.42% | - | -314.29% | - | |
| Free Cash Flow Per Share | 2.12 | -4.35 | -4.31 | -2.83 | -2.71 | -2.40 | |
| Cash Income Tax Paid | 2.25 | - | - | - | - | - | |
| Levered Free Cash Flow | 49.53 | -108.31 | -81.25 | -33.84 | -39.48 | -22.38 | |
| Unlevered Free Cash Flow | 49.53 | -108.31 | -81.25 | -33.84 | -39.48 | -22.37 | |
| Change in Working Capital | -10.04 | -11.44 | -2.65 | 14.31 | -16.07 | 2.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.